These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7308514)

  • 1. Bromocriptine reduction of prolactinoma size.
    Corenblum B; Hanley DA
    Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
    Niwa J; Sato O; Tanabe S
    Comput Radiol; 1983; 7(4):237-41. PubMed ID: 6641185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA; Chang RJ
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactinomas and optic nerve compression: disappearance of suprasellar extension and visual recovery after two weeks bromocriptine treatment.
    Woodhouse NJ; Khouqueer F; Sieck JO
    Horm Res; 1981; 14(3):141-7. PubMed ID: 7286886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective management of a suprasellar extending prolactinoma during pregnancy.
    Pittini L; Minisci N; Negri P
    Clin Exp Obstet Gynecol; 1987; 14(3-4):152-4. PubMed ID: 3454722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible "hypopituitarism" and disappearance of microadenoma in a prolactinoma patient treated with bromocriptine.
    Ayers JW
    Fertil Steril; 1983 Dec; 40(6):846-8. PubMed ID: 6653805
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid rhinorrhea during treatment with bromocriptine for prolactinoma.
    Kok JG; Bartelink AK; Schulte BP; Smals A; Pieters G; Meyer E; Merx H
    Neurology; 1985 Aug; 35(8):1193-5. PubMed ID: 4022353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment by computed tomography of the response of pituitary macroadenomas to bromocriptine.
    Chakera TM; Khangure MS; Pullen P
    Clin Radiol; 1985 May; 36(3):223-6. PubMed ID: 4064503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
    Breidahl HD; Topliss DJ; Pike JW
    Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid decompression of anterior intracranial visual pathways with bromocriptine.
    Grimson BS; Bowman ZL
    Arch Ophthalmol; 1983 Apr; 101(4):604-6. PubMed ID: 6838419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term treatment with bromocriptine on pituitary prolactinoma in a male.
    Ayalon D; Eckstein N; Homonnai ZT; Paz GF; Eshel A; Reider I
    Int J Gynaecol Obstet; 1982 Dec; 20(6):481-5. PubMed ID: 6130996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
    Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
    J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy.
    Tan SL; Jacobs HS
    Int J Gynaecol Obstet; 1986 Jun; 24(3):209-15. PubMed ID: 2880760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
    Verde G; Loli P; Berselli ME; Tagliaferri M; Dallabonzana D; Oppizzi G; Liuzzi A; Chiodini PG; Luccarelli G; Lodrini S
    J Endocrinol Invest; 1984 Feb; 7(1):51-4. PubMed ID: 6715796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.
    Canales ES; García IC; Ruíz JE; Zárate A
    Fertil Steril; 1981 Oct; 36(4):524-6. PubMed ID: 7286276
    [No Abstract]   [Full Text] [Related]  

  • 18. Normal growth and pubertal development during bromocriptine treatment for a prolactin-secreting pituitary macroadenoma.
    Dalzell GW; Atkinson AB; Carson DJ; Sheridan B
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):169-72. PubMed ID: 3665115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
    Boulanger CM; Mashchak CA; Chang RJ
    Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
    N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.